참고문헌
- Ali AM, Mir R, Bashir S, et al (2011). Relationship between the levels of serum thyroid hormones and the risk of breast cancer. J Biology Agriculture Healthcare, 1, 56-9.
- Altman DG (1998). Sbe24: metan-an alternative meta-analysis command. Stata Tech Bull Reprints, 8, 86-100.
- Altman DG (2001). Systematic reviews of evaluations of prognostic variables. BMJ, 323, 224-8. https://doi.org/10.1136/bmj.323.7306.224
- Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
- Biondi B, Cooper DS (2008). The clinical significance of subclinical thyroid dysfunction. Endocr Rev, 29, 76-131. https://doi.org/10.1210/er.2006-0043
- Cengiz O, Bozkurt B, Unal B, et al (2004). The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol, 87, 19-25. https://doi.org/10.1002/jso.20071
- Colditz GA, Burdick E, Mosteller F (1995). Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol, 142, 371-82.
- Dai G, Levy O, Carrasco N (1996). Cloning and characterization of the thyroid iodide transporter. Nature, 379, 458-60. https://doi.org/10.1038/379458a0
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
- Dinda S, Sanchez A, Moudgil V (2002). Estrogen-like effects of thyroid hormone on the regulation of tumor suppressor proteins, p53 and retinoblastoma, in breast cancer cells. Oncogene, 21, 761-8. https://doi.org/10.1038/sj.onc.1205136
- Ditsch N, Liebhardt S, Von Koch F, et al (2010). Thyroid function in breast cancer patients. Anticancer Res, 30, 1713-7.
- Egger M, Smith GD, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Farahati J, Roggenbuck D, Gilman E, et al (2012). Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer. Clin Chem Lab Med, 50, 709-14.
- Giustarini E, Pinchera A, Fierabracci P, et al (2006). Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. Eur J Endocrinol, 154, 645-9. https://doi.org/10.1530/eje.1.02108
- Harris RJ, Bradburn MJ, Deeks JJ, et al (2008). metan: fixed-and random-effects meta-analysis. Stata J, 8, 3-28.
- Hellevik AI, Asvold BO, Bjoro T, et al (2009). Thyroid function and cancer risk: a prospective population study. Cancer Epidemiol Biomarkers Prev, 18, 570-4. https://doi.org/10.1158/1055-9965.EPI-08-0911
- Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
- Kogai T, Curcio F, Hyman S, et al (2000). Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol, 167, 125-35. https://doi.org/10.1677/joe.0.1670125
- Kuijpens JL, Nyklictek I, Louwman MW, et al (2005). Hypothyroidism might be related to breast cancer in postmenopausal women. Thyroid, 15, 1253-9. https://doi.org/10.1089/thy.2005.15.1253
- Mittal A, Poudel B, Pandeya DR, et al (2012). Metabolic changes enhance the cardiovascular risk with differentiated thyroid carcinoma a case control study from Manipal Teaching Hospital of Nepal. Asian Pac J Cancer Prev, 13, 2335-8. https://doi.org/10.7314/APJCP.2012.13.5.2335
- Nogueira CR, Brentani MM (1996). Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol, 59, 271-9. https://doi.org/10.1016/S0960-0760(96)00117-3
- Prinzi N, Baldini E, Sorrenti S, et al (2014). Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3, 921 patients. Breast Cancer Res Treat, 144, 683-8. https://doi.org/10.1007/s10549-014-2893-y
- Saito T, Endo T, Kawaguchi A, et al (1997). Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab, 82, 3331-6.
- Saraiva PP, Figueiredo NB, Padovani CR, et al (2005). Profile of thyroid hormones in breast cancer patients. Braz J Med Biol Res, 38, 761-5.
- Simon MS, Tang MT, Bernstein L, et al (2002). Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev, 11, 1574-8.
- Smyth P, Smith D, Dermott EM, et al (1996). A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab, 81, 937-41.
- Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283, 2008-12. https://doi.org/10.1001/jama.283.15.2008
- Szychta P, Szychta W, Gesing A, et al (2013). TSH receptor antibodies have predictive value for breast cancerretrospective analysis. Thyroid Res, 6, 8. https://doi.org/10.1186/1756-6614-6-8
- Tazebay UH, Wapnir IL, Levy O, et al (2000). The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med, 6, 871-8. https://doi.org/10.1038/78630
- Turken O, NarIn Y, DemIrbas S, et al (2003). Breast cancer in association with thyroid disorders. Breast Cancer Res, 5, 110-3. https://doi.org/10.1186/bcr609
- Uyeturk U, Tatli AM, Gucuk S, et al (2013). Risk factors for stage IV breast cancer at the time of presentation in Turkey. Asian Pac J Cancer Prev, 14, 7445-9. https://doi.org/10.7314/APJCP.2013.14.12.7445
- Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011). The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab, 96, 1-8.
- Vanderpump MP (2011). The epidemiology of thyroid disease. Br Med Bull, 99, 39-51. https://doi.org/10.1093/bmb/ldr030
- Weiss HA, Brinton LA, Potischman NA, et al (1999). Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol, 28, 816-23. https://doi.org/10.1093/ije/28.5.816
피인용 문헌
- Thyroid Autoantibodies and Breast Cancer vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10999
- Immunosignature: Serum Antibody Profiling for Cancer Diagnostics vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4833
- COMMENTARY ON “STUDY OF THE PREVALENCE OF AUTOIMMUNE THYROID DISEASE IN WOMEN WITH BREAST CANCER” vol.22, pp.1, 2016, https://doi.org/10.4158/EP151035.CO
- The thyroid and breast cancer vol.23, pp.5, 2016, https://doi.org/10.1097/MED.0000000000000273
- Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases vol.8, pp.1664-3224, 2017, https://doi.org/10.3389/fimmu.2017.00521
- Overexpression of modified human TRβ1 suppresses the growth of hepatocarcinoma SK-hep1 cells in vitro and in xenograft models pp.1573-4919, 2018, https://doi.org/10.1007/s11010-018-3357-1